the southwestern oncology group is conducting a controlled clinical trial for patients with all types of advanced non-hodgkin 's lymphoma in which chemoimmunotherapy ( chop + bcg ) is being compared with chemotherapy alone ( chop + bleomycin or cop + bleomycin ) for remission induction .
C0024305
non-hodgkin 's lymphoma
C0005740
bleomycin